------------- -------------- ------------------- -------------------
Wednesday , January 20 2021

MOH authorizes use of Bamlanivimab to treat mild to moderate cases of COVID

KUWAIT CITY, Dec 1: Kuwait’s Ministry of Health (MoH) authorized the drug “Bamlanivimab” for emergency use to treat mild to moderate cases of COVID-19 in adult patients and kids over 12 years old who have risk factors that make them more vulnerable.

Assistant Undersecretary for Drug and Food Control Affairs Dr Abdullah Al- Bader said, in a press statement on Tuesday, that the last emergency use of Baricitinib was licensed to be used as an added drug to Remdesivir to treat COVID-19 cases in adult patients and children over two years old who are receiving hospital treatment with ventilators. (KUNA)

Check Also

MoH spokesman stresses stability of COVID totals

KUWAIT CITY, Jan 14, (KUNA): Kuwait has become one of the countries that witness a …

You have installed adblocker kindly disable

whitelist www.arabtimesonline.com




Translate »